rs12313200

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002336.3(LRP6):​c.3970+165C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 152,114 control chromosomes in the GnomAD database, including 1,545 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1545 hom., cov: 31)

Consequence

LRP6
NM_002336.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.18

Publications

10 publications found
Variant links:
Genes affected
LRP6 (HGNC:6698): (LDL receptor related protein 6) This gene encodes a member of the low density lipoprotein (LDL) receptor gene family. LDL receptors are transmembrane cell surface proteins involved in receptor-mediated endocytosis of lipoprotein and protein ligands. The protein encoded by this gene functions as a receptor or, with Frizzled, a co-receptor for Wnt and thereby transmits the canonical Wnt/beta-catenin signaling cascade. Through its interaction with the Wnt/beta-catenin signaling cascade this gene plays a role in the regulation of cell differentiation, proliferation, and migration and the development of many cancer types. This protein undergoes gamma-secretase dependent RIP- (regulated intramembrane proteolysis) processing but the precise locations of the cleavage sites have not been determined.[provided by RefSeq, Dec 2009]
BCL2L14 (HGNC:16657): (BCL2 like 14) The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Overexpression of this gene has been shown to induce apoptosis in cells. Three alternatively spliced transcript variants encoding two distinct isoforms have been reported for this gene. [provided by RefSeq, May 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-12131656-G-A is Benign according to our data. Variant chr12-12131656-G-A is described in ClinVar as Benign. ClinVar VariationId is 1229993.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP6NM_002336.3 linkc.3970+165C>T intron_variant Intron 18 of 22 ENST00000261349.9 NP_002327.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP6ENST00000261349.9 linkc.3970+165C>T intron_variant Intron 18 of 22 1 NM_002336.3 ENSP00000261349.4

Frequencies

GnomAD3 genomes
AF:
0.133
AC:
20211
AN:
151996
Hom.:
1548
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0839
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.208
Gnomad EAS
AF:
0.0190
Gnomad SAS
AF:
0.0626
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.161
Gnomad OTH
AF:
0.163
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.133
AC:
20220
AN:
152114
Hom.:
1545
Cov.:
31
AF XY:
0.132
AC XY:
9837
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0840
AC:
3483
AN:
41480
American (AMR)
AF:
0.162
AC:
2478
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
721
AN:
3472
East Asian (EAS)
AF:
0.0194
AC:
101
AN:
5194
South Asian (SAS)
AF:
0.0639
AC:
308
AN:
4818
European-Finnish (FIN)
AF:
0.154
AC:
1631
AN:
10566
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.161
AC:
10971
AN:
67990
Other (OTH)
AF:
0.162
AC:
341
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
919
1838
2757
3676
4595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
704
Bravo
AF:
0.134
Asia WGS
AF:
0.0440
AC:
156
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
12
DANN
Benign
0.19
PhyloP100
1.2
PromoterAI
0.019
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12313200; hg19: chr12-12284590; API